Lenalidomide plus Rituximab for Mantle-Cell Lymphoma

N Engl J Med. 2016 Feb 25;374(8):792-3. doi: 10.1056/NEJMc1515465.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Thalidomide / analogs & derivatives*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Thalidomide